Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Capital Expenditures (2016 - 2024)

Arcadia Biosciences filings provide 11 years of Capital Expenditures readings, the most recent being $3000.0 for Q2 2024.

  • On a quarterly basis, Capital Expenditures fell 40.0% to $3000.0 in Q2 2024 year-over-year; TTM through Mar 2025 was $3000.0, a 83.33% decrease, with the full-year FY2024 number at $16000.0, up 220.0% from a year prior.
  • Capital Expenditures hit $3000.0 in Q2 2024 for Arcadia Biosciences, down from $13000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $971000.0 in Q2 2020 to a low of -$2.0 million in Q4 2020.
  • Median Capital Expenditures over the past 5 years was $64000.0 (2021), compared with a mean of $83642.9.
  • The widest YoY moves for Capital Expenditures: up 784.09% in 2020, down 124.29% in 2020.
  • Arcadia Biosciences' Capital Expenditures stood at -$2.0 million in 2020, then skyrocketed by 104.47% to $88000.0 in 2021, then crashed by 70.45% to $26000.0 in 2022, then plummeted by 80.77% to $5000.0 in 2023, then tumbled by 40.0% to $3000.0 in 2024.
  • The last three reported values for Capital Expenditures were $3000.0 (Q2 2024), $13000.0 (Q1 2024), and $5000.0 (Q2 2023) per Business Quant data.